• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.使用他莫昔芬诱导的 PlpCre 对围产期或成年 NF1 进行失活,均可导致神经纤维瘤的形成。
Cancer Res. 2011 Jul 1;71(13):4675-85. doi: 10.1158/0008-5472.CAN-10-4558. Epub 2011 May 6.
2
Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.施万细胞中对 NF1 相关丛状神经纤维瘤发展敏感的阶段。
Cancer Res. 2011 Jul 1;71(13):4686-95. doi: 10.1158/0008-5472.CAN-10-4577. Epub 2011 May 6.
3
Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST.神经纤维瘤模型中的丧失显示出典型神经纤维瘤和恶性外周神经鞘瘤的逐步肿瘤进展。
Cancer Res. 2020 Nov 1;80(21):4720-4730. doi: 10.1158/0008-5472.CAN-19-1429. Epub 2020 Aug 19.
4
Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.1型神经纤维瘤病中良性和恶性肿瘤的17号染色体杂合性缺失研究
Genes Chromosomes Cancer. 2000 Aug;28(4):425-31.
5
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.丛状和皮肤神经纤维瘤以及色素沉着是由表达沙漠刺猬蛋白的细胞中Nf1缺失引起的。
Cancer Cell. 2008 Feb;13(2):105-16. doi: 10.1016/j.ccr.2007.12.027.
6
Neurofibromas in NF1: Schwann cell origin and role of tumor environment.1型神经纤维瘤病中的神经纤维瘤:施万细胞起源及肿瘤环境的作用
Science. 2002 May 3;296(5569):920-2. doi: 10.1126/science.1068452.
7
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.血管生成因子中期因子在神经纤维瘤病1型(NF1)缺陷的施万细胞中异常表达,并且是神经纤维瘤来源细胞的促分裂原。
Oncogene. 2001 Jan 4;20(1):97-105. doi: 10.1038/sj.onc.1204026.
8
NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.散发型及1型神经纤维瘤病(NF1)相关丛状神经纤维瘤和恶性外周神经鞘瘤中S-100蛋白阳性和阴性细胞的NF1缺失
Am J Pathol. 2001 Jul;159(1):57-61. doi: 10.1016/S0002-9440(10)61673-2.
9
Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.神经纤维瘤病1型相关恶性外周神经鞘膜瘤突变图谱的确认
Genes Chromosomes Cancer. 2017 May;56(5):421-426. doi: 10.1002/gcc.22446. Epub 2017 Mar 7.
10
Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.在NF1基因第38内含子存在杂合性缺失的丛状神经纤维瘤以及NF1基因无杂合性缺失的皮肤神经纤维瘤中肿瘤细胞的克隆起源。
Biochem Biophys Res Commun. 1997 May 19;234(2):346-50. doi: 10.1006/bbrc.1997.6645.

引用本文的文献

1
Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.神经纤维瘤蛋白1缺失加速葡萄膜和皮内黑色素瘤的肿瘤发生,且致癌性GNAQ可转化雪旺细胞。
Cancer Res Commun. 2025 Feb 1;5(2):209-225. doi: 10.1158/2767-9764.CRC-24-0386.
2
The +/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation.±免疫微环境:在神经纤维瘤发生发展及恶性转化中的双重作用
Cancers (Basel). 2024 Feb 29;16(5):994. doi: 10.3390/cancers16050994.
3
Stem cell modeling of nervous system tumors.神经系统肿瘤的干细胞建模。
Dis Model Mech. 2024 Feb 1;17(2). doi: 10.1242/dmm.050533. Epub 2024 Feb 14.
4
Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.针对髓鞘的1型神经纤维瘤病基因突变会损害特定性别的精细运动技能学习。
Cancers (Basel). 2024 Jan 23;16(3):477. doi: 10.3390/cancers16030477.
5
Schwann cell derived pleiotrophin stimulates fibroblast for proliferation and excessive collagen deposition in plexiform neurofibroma.雪旺细胞源性多效生长因子刺激成纤维细胞增殖并导致丛状神经纤维瘤中胶原蛋白过度沉积。
Cancer Gene Ther. 2024 Apr;31(4):627-640. doi: 10.1038/s41417-024-00727-1. Epub 2024 Feb 2.
6
[Gene therapy strategies and prospects for neurofibromatosis type 1].[1型神经纤维瘤病的基因治疗策略与前景]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Jan 15;38(1):1-8. doi: 10.7507/1002-1892.202309071.
7
Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.细胞外基质中的基底膜蛋白可表征 NF1 神经纤维瘤的发展以及对 MEK 抑制剂的反应。
J Clin Invest. 2023 Jun 15;133(12):e168227. doi: 10.1172/JCI168227.
8
Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.1型神经纤维瘤病中的神经纤维瘤发生:来自细胞起源和施万细胞谱系发育的见解
Cancers (Basel). 2022 Sep 17;14(18):4513. doi: 10.3390/cancers14184513.
9
A genetic mouse model with postnatal and loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor.一种具有出生后及缺失情况的基因小鼠模型概括了人类恶性外周神经鞘瘤的组织学和转录组。
Neurooncol Adv. 2021 Sep 10;3(1):vdab129. doi: 10.1093/noajnl/vdab129. eCollection 2021 Jan-Dec.
10
Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.Mek/ERK1/2-MAPK 和 PI3K/Akt/mTOR 信号通路在施万细胞分化、髓鞘形成和脱髓鞘中发挥独立和协同作用。
Glia. 2021 Oct;69(10):2429-2446. doi: 10.1002/glia.24049. Epub 2021 Jun 22.

本文引用的文献

1
Characterization of OP9 as authentic mesenchymal stem cell line.鉴定 OP9 为真正的间充质干细胞系。
J Genet Genomics. 2010 Jul;37(7):475-82. doi: 10.1016/S1673-8527(09)60067-9.
2
Neurofibromatosis type 1 and high-grade tumors of the central nervous system.1型神经纤维瘤病与中枢神经系统高级别肿瘤
Childs Nerv Syst. 2010 May;26(5):663-7. doi: 10.1007/s00381-009-1024-2. Epub 2009 Nov 25.
3
Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow.小鼠骨髓中多能间充质干细胞的前瞻性鉴定、分离及全身移植
J Exp Med. 2009 Oct 26;206(11):2483-96. doi: 10.1084/jem.20091046. Epub 2009 Oct 19.
4
Neurofibromatosis type 1.1型神经纤维瘤病
J Am Acad Dermatol. 2009 Jul;61(1):1-14; quiz 15-6. doi: 10.1016/j.jaad.2008.12.051.
5
Endochondral ossification is required for haematopoietic stem-cell niche formation.造血干细胞龛的形成需要软骨内成骨。
Nature. 2009 Jan 22;457(7228):490-4. doi: 10.1038/nature07547. Epub 2008 Dec 10.
6
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.Nf1基因依赖型肿瘤需要一个包含Nf1+/-和c-kit基因依赖型骨髓的微环境。
Cell. 2008 Oct 31;135(3):437-48. doi: 10.1016/j.cell.2008.08.041.
7
Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation.控制胚胎期雪旺细胞发育、髓鞘形成和去分化的新信号。
J Peripher Nerv Syst. 2008 Jun;13(2):122-35. doi: 10.1111/j.1529-8027.2008.00168.x.
8
Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad.小鼠骨髓、背根神经节和触须垫中神经嵴衍生干细胞的个体发生和多能性。
Cell Stem Cell. 2008 Apr 10;2(4):392-403. doi: 10.1016/j.stem.2008.03.005.
9
The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.Nf1的缺失会短暂促进神经嵴干细胞的自我更新,但不会促进其肿瘤发生。
Cancer Cell. 2008 Feb;13(2):129-40. doi: 10.1016/j.ccr.2008.01.003.
10
Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.非髓鞘施万细胞诱导异常增殖会引发神经纤维瘤的形成。
Cancer Cell. 2008 Feb;13(2):117-28. doi: 10.1016/j.ccr.2008.01.002.

使用他莫昔芬诱导的 PlpCre 对围产期或成年 NF1 进行失活,均可导致神经纤维瘤的形成。

Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.

机构信息

Cincinnati Children's Hospital Medical Center; Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA.

出版信息

Cancer Res. 2011 Jul 1;71(13):4675-85. doi: 10.1158/0008-5472.CAN-10-4558. Epub 2011 May 6.

DOI:10.1158/0008-5472.CAN-10-4558
PMID:21551249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3464476/
Abstract

Plexiform neurofibromas are peripheral nerve sheath tumors initiated by biallelic mutation of the NF1 tumor suppressor gene in the Schwann cell lineage. To understand whether neurofibroma formation is possible after birth, we induced Nf1 loss of function with an inducible proteolipid protein Cre allele. Perinatal loss of Nf1 resulted in the development of small plexiform neurofibromas late in life, whereas loss in adulthood caused large plexiform neurofibromas and morbidity beginning 4 months after onset of Nf1 loss. A conditional EGFP reporter allele identified cells showing recombination, including peripheral ganglia satellite cells, peripheral nerve S100β+ myelinating Schwann cells, and peripheral nerve p75+ cells. Neurofibromas contained cells with Remak bundle disruption but no recombination within GFAP+ nonmyelinating Schwann cells. Extramedullary lympho-hematopoietic expansion was also observed in PlpCre;Nf1fl/fl mice. These tumors contained EGFP+/Sca-1+ stromal cells among EGFP-negative lympho-hematopoietic cells indicating a noncell autonomous effect and unveiling a role of Nf1-deleted microenvironment on lympho-hematopoietic proliferation in vivo. Together these findings define a tumor suppressor role for Nf1 in the adult and narrow the range of potential neurofibroma-initiating cell populations.

摘要

丛状神经纤维瘤是由施万细胞谱系中 NF1 肿瘤抑制基因的双等位基因突变引发的周围神经鞘肿瘤。为了了解神经纤维瘤是否可能在出生后形成,我们使用诱导型蛋白脂质蛋白 Cre 等位基因诱导 Nf1 功能丧失。围产期 Nf1 的缺失导致生命后期小型丛状神经纤维瘤的发生,而成年期的缺失则导致大型丛状神经纤维瘤和发病,发病后 4 个月开始出现发病。条件性 EGFP 报告基因等位基因鉴定了发生重组的细胞,包括周围神经节卫星细胞、周围神经 S100β+髓鞘形成施万细胞和周围神经 p75+细胞。神经纤维瘤包含 Remak 束中断的细胞,但在 GFAP+非髓鞘形成施万细胞中没有重组。在 PlpCre;Nf1fl/fl 小鼠中还观察到骨髓外淋巴造血系统的扩张。这些肿瘤在 EGFP 阴性的淋巴造血细胞中含有 EGFP+/Sca-1+基质细胞,表明存在非细胞自主效应,并揭示了 Nf1 缺失的微环境对体内淋巴造血细胞增殖的作用。这些发现共同定义了 Nf1 在成年期的肿瘤抑制作用,并缩小了潜在的神经纤维瘤起始细胞群体的范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/e9a5ac08eb5d/nihms289100f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/8e9fa9e86e69/nihms289100f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/37be7f85fbb8/nihms289100f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/66f2d8338b20/nihms289100f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/d99698be4c9f/nihms289100f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/4e913694c17c/nihms289100f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/bb05246628bf/nihms289100f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/e9a5ac08eb5d/nihms289100f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/8e9fa9e86e69/nihms289100f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/37be7f85fbb8/nihms289100f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/66f2d8338b20/nihms289100f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/d99698be4c9f/nihms289100f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/4e913694c17c/nihms289100f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/bb05246628bf/nihms289100f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/3464476/e9a5ac08eb5d/nihms289100f7.jpg